Inhibitory effects of grape seed procyanidins on foam cell formation in vitro

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 6, 2009, Pages 2588-2594

  Terra, Ximena ^a   Fernández Larrea, Juan ^a   Pujadas, Gerard ^a   Ardèvol, Anna ^a   Bladé, Cinta ^a   Salvadó, Josepa ^a   Arola, Luis ^a   Blay, Mayte ^a,b  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Department of Biochemistry and Biotechnology ^*  (Spain)

Author keywords

ABCA1; Atherogenesis; CD36; Cholesterol; Oxidized lipoproteins; Procyanidins

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROANTHOCYANIDIN; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; FOAM CELL; GENE EXPRESSION; GENETICS; GRAPE; INFLAMMATION; MACROPHAGE; METABOLISM; MOUSE; PLANT SEED;

ANIMALS; CELL LINE; CHOLESTEROL; FOAM CELLS; GENE EXPRESSION; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; PROANTHOCYANIDINS; SEEDS; TRIGLYCERIDES; VITIS;

ANIMALIA; EQUUS ASINUS; VITACEAE;

EID: 64549154448     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803450a     Document Type: Article

References (34)

1. Terra, X.; Valls, J.; Vitrac, X.; Merrillon, J.-M.; Arola, L.; Ardevol, A.; Blade, C.; Femandez-Larrea, J.; Pujadas, G.; Salvado, J.; Blay, M. Grape-seed procyanidins act as antiinflammatory agents in endotoxin-stimulated RAW 264.7 macrophages by inhibiting NFkB signaling pathway. J. Agric. Food Chem. 2007, 55, 4357-4365.
2. Bagchi, D.; Sen, C. K.; Ray, S. D.; Das, D. K.; Bagchi, M.; Preuss, H. G.; Vinson, J. A. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat. Res. 2003, 523-524, 87-97.
3. Rasmussen, S. E.; Frederiksen, H.; Krogholm, K. S.; Poulsen, L. Dietary proanthocyanidins: occurrence, dietary intake, bioavail-ability. and protection against cardiovascular disease. Mol. Nutr. Food. Res. 2005, 49, 159-174.
4. Ariga, T. The antioxidative function, preventive action on disease and utilization of proanthocyanidins. BioFactors 2004, 21, 197-201.
5. Chen, D.-M.; Cai, X.; Kwik-Uribe, C. L.; Zeng, R.; Zhu, X.-Z. Inhibitory effects of procyanidin B2 dimer on lipid-laden macrophage formation. J. Cardiovasc. Pharmacol. 2006, 48, 54-70.
6. Glass, C. K.; Witztum, J. L. Atherosclerosis: the road ahead. Cell 2001. 104, 503-516.
7. Moore, K. J.; Freeman, M. W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1702-1711.
8. Chinetti, G.; Lestavel, S.; Fruchart, J.; Clavey, V.; Staels, B. Peroxisome proliferator-activated receptor α reduces cholesterol esterification in macrophages. Circ. Res. 2003, 92, 212-217.
9. Nicholson, A. C. Expression of CD36 in macrophages and atherosclerosis the role of lipid regulation of PPAR[γ] signaling. Trends Cardiovasc. Med. 2004, 14, 8-12.
10. Kavanagh, I. C.; Symes, C. E.; Renaudin, P.; Nova, E.; Mesa, M. D.; Boukouvalas, G.; Leake, D. S.: Yaqoob, P. Degree of oxidation of low density lipoprotein affects expression of CD36 and PPAR[γ], but not cytokine production, by human monocyte-macrophages. Atherosclerosis 2003, 168, 271-282.
11. Chinetti, G.; Lestavel, S.; Bocher, V.; Remaley, A. T.; Neve, B.; Torra, I. P.; Teissier, E.; Minnich, A.; Jaye, M.; Duverger, N.; Brewer, H. B.; Fruchart, J.-C.; Clavey, V.; Staels, B. PPAR-[α] and PPAR-[γ] activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 2001, 7, 53-58.
12. Takata, Y.; Chu, V.; Collins, A. R.; Lyon, C. J.; Wang, W.: Blaschke, F.; Bruemmer, D.; Caglayan, E.; Daley, W.; Higaki, J.; Fishbein, M. C.; Tangirala, R. K.; Law, R. E.; Hsueh, W. A. Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II. Circ. Res. 2005, 97, e88-96.
13. Marcil, V.; Delvin, E.; Sane, A. T.; Tremblay, A.; Levy, E. Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors. Cardiovasc. Res. 2006, 72, 473-482.
14. Li, A. C.; Glass, C. K. The macrophage foam cell as a target for therapeutic intervention, Nat. Med. 2002, 8, 1235-1242.
15. Kumagai, T.; Matsukawa, N.; Kaneko, Y.; Kusumi, Y.; Mitsumata, M.; Uchida, K. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J. Bliol. Chem. 2004, 279, 48389-48396.
16. Li, Y.; Schwabe, R. F.; DeVries-Seimon, T.; Yao, P. M.; Gerbod-Giannone, M.-C.; Tall, A. R.; Davis, R. J.; Flavell, R.; Brenner, D. A.; Tabas, I. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-{α}and interleukin-6: model of NF-{κ}B- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 2005, 280, 21763-21772.
17. Castrillo, A.; Joseph, S. B.; Vaidya, S. A.; Haberland, M.; Fogelman, A. M.; Cheng, G.; Tontonoz, P. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 2003, 12, 805-816.
18. Baranova, I.; Vishnyakova, T.; Bocharov, A.; Chen, Z.; Remaley, A. T.; Stonik, J.; Eggerman, T. L.; Patterson, A. P. Lipopolysac-charide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect. Immun. 2002, 70, 2995-3003.
19. Groeneweg, M.; Kanters, E.; Vergouwe, M. N.; Duerink, H.: Kraal, G.; Hofker, M. H.; de Winther, M. P. J. Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL. J. Lipid Res 2006, 47, 2259-2267.
20. Batt, K. V.; Avella, M.; Moore, E. H.; Jackson, B.; Suckling, K. E.; Botham, K. M. Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Exp. Biol. Med. 2004, 229, 528-537.
21. Chow, H.-H. S.; Hakim, I. A.; Vining, D. R.; Crowell, J. A.; Ranger-Moore, J.; Chew, W. M.; Celaya, C. A.; Rodney, S. R.; Hara, Y.; Alberts, D. S. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin. Cancer Res. 2005, 11, 4627-4633.
22. Keogh, J. B.; McInerney, J.; Clifton, P. M. The effect of milk protein on the bioavailability of cocoa polyphenols. J. Food Sci. 2007, 72, S230-S233.
23. Shoji, T.; Masumoto, S.; Moriichi, N.; Akiyama, H.; Kanda, T.; Ohtake, Y.; Goda, Y. Apple procyanidin oligomers absorption in rats after oral administration: analysis of procyanidins in plasma using the porter method and high-performance liquid chromatog-raphy/tandem mass spectrometry. J. Agric. Food Chem. 2006, 54, 884-892.
24. Matsuura, E.; Kobayashi, K.; Tabuchi, M.; Lopez, L. R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 2006, 45, 466-486.
25. Siow, R. C. M.; Richards, J. P.; Pedley, K. C.; Leake, D. S.; Mann, G. E. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 2387-2394.
26. Covas, M. Bioactive effects of olive oil phenolic compounds in humans: reduction of heart disease factors and oxidative damage. Inflammopharmacology 2008, 16, 216-218.
27. Carmeli, E.; Harpaz, Y.; Kogan, N.; Fogelman, Y. The effect of an endogenous antioxidant glabridin on oxidized LDL. J. Basic Clin. Physiol. Pharmacol. 2008, 19, 49-63.
28. Jedidi, I.; Couturier, M.; Therond, P.; Gardes-Albert, M.; Legrand, A.; Barouki, R.; Bonnefont-Rousselot, D.; Aggerbeck, M. Cho-lesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPAR[α]. Biochem. Biophys. Res. Commun. 2006, 351, 733-738.
29. Xia, M.; Hou, M.; Zhu, H.; Ma, J.; Tang, Z.; Wang, Q.; Li, Y.: Chi, D.; Yu, X.; Zhao, T.; Han, P.; Xia, X.; Ling, W. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor γ-liver × receptor α-ABCA1 pathway. J. Biol. Chem. 2005, 280, 36792-36801.
30. Taketa, K.; Matsumura, T.; Yano, M.; Ishii, N.; Senokuchi, T.; Motoshima, H.; Murata, Y.; Kim-Mitsuyama, S.; Kawada, T.; Itabe, H.; Takeya, M.; Nishikawa, T.; Tsuruzoe, K.; Araki, E. Ox-LDL activates PPARα and PPARγ through MAPK-dependent COX-2 expression in macrophages. J. Biol. Chem. 2008, M703318200.
31. Janabi, M.; Yamashita, S.; Hirano, K.-i.; Sakai, N.; Hiraoka, H.; Matsumoto, K.; Zhang, Z.; Nozaki, S.; Matsuzawa, Y. Oxidized LDL-induced NF-{κ}B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1953-1960.
32. Ferreira, V.; van Dijk, K. W.; Groen, A. K.; Vos, R. M.; van der Kaa, J.; Gijbels, M. J. J.: Havekes, L. M.; Pannekoek, H. Macrophage-specific inhibition of NF-[κ]B activation reduces foam-cell formation. Atherosclerosis 2007, 192, 283-290.
33. Karin, M.; Ben-Neriah. Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol. 2000, 18, 621-663.
34. Behr-Roussel, D.; Rupin, A.; Simonet, S.; Bonhomme, E.; Coumailleau, S.; Cordi, A.; Serkiz, B.; Fabiani, J.-N.; Verbeuren, T. J. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercho-lesterolemic rabbits. Circulation 2000. 102, 1033-1038.